Medical Technology
Abstract
This Program Element (PE) supports application of knowledge gained through basic research to refine drugs, vaccines, medical devices, diagnostics, medical practices/ procedures, and other preventive measures essential to the protection and sustainment of Warfighter health. Research is conducted in five principal areas: Combat Casualty Care, Military Operational Medicine, Military Relevant Infectious Diseases, Clinical and Rehabilitative Medicine, Medical Capabilities to Support Dispersed Operations, and Systems Biology/Network Sciences. Projects are coordinated with the Defense Health Agency. The cited research is consistent with the Under Secretary of Defense for Research and Engineering science and technology focus areas and the Army Modernization Strategy. All medical applied research is conducted in compliance with Food and Drug Administration (FDA) or Environmental Protection Agency (EPA) regulations. The FDA requires thorough testing in animals (preclinical testing) to ensure safety and, where possible, effectiveness prior to evaluation in controlled human clinical trials (upon transition to Advanced Technology Development). This PE focuses on research and refinement of technologies such as product formulation and purification and laboratory test refinement with the aim of identifying candidate solutions. This work often involves testing in animal models. The EPA also requires thorough testing of products, such as sterilants, disinfectants, repellents, and insecticides to ensure the environment is adequately protected before these products are licensed for use. Program refinement and execution is externally peer-reviewed and fully coordinated with all Services as well as other agencies through the Joint Technology Coordinating Groups of the Biomedical Community of Interest. The Biomedical Community of Interest, formed under the authority of the Assistant Secretary of Defense for Research and Engineering, serves to facilitate coordination and prevent unnecessary duplication of effort within the Department of Defenses (DoD) biomedical research community, as well as their associated enabling research areas.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2025
- Source ID
- 0602787A_2_2040_PB_2025
- Change Summary Explanation
- Funding decrease reflect planned lifecycle for this effort.
- Service Agency Name
- Army
Entities
Organizations
- United States Army
Related Documents
- Child Project: Medical Technology (CA)
- Child Project: Warfigher Health Applied Rsch Technology
- Child Accomplishment: Operational Risk Planning Tools for Battlefield Environmental Threats
- Child Accomplishment: Prevention of Soldier Performance Degradation in Extreme Environments
- Child Accomplishment: Leader Decision Aid to Manage Blast Head Injury in All Settings
- Child Accomplishment: Physical Fitness Standards to Prevent Musculoskeletal Injuries
- Child Accomplishment: Leader Tools to Reduce Musculoskeletal Injury In All Settings
- Child Accomplishment: Forward Neuro-Muscular Skeletal Injury Assessment
- Child Accomplishment: Biomedical Performance Enhancement
- Child Accomplishment: Expeditionary Force Nutrition to Improve Performance
- Child Accomplishment: Energy Field Biological Effects and Mechanisms
- Child Project: Cbt Casualty Care Applied Rsch Technology
- Child Accomplishment: Future En Route Casualty Care Sustainment System Cap Set
- Child Project: Medical Technologies to Support Dispersed Ops Tech
- Child Accomplishment: Medical Robotic and Autonomous Systems